After a period of waiting, it was finally made known that a Xarelto lawsuit has been filed before the Philadelphia Court of Common Pleas in Pennsylvania on February 24, 2014. Complainant in this Xarelto lawsuit filed before Judge Joel H. Slomsky was identified as Virginia G. Stuntebeck, from the state of Kentucky. Legal observers believe that with this filing, more Xarelto lawsuits may be expected to be filed in different state and federal courts across the United States. By checking http://www.xareltoinjuryfirm.com, injured patients who may not be too acquainted with the process and who wish to get possible compensation for the harm they sustained may learn more about their options.
Plaintiff Experienced Complications after Xarelto Prescription
Virginia Stuntebeck stated in her complaint that she was prescribed with Xarelto medication by her attending physician for her atrial fibrillation in July 2012. She started experiencing severe complications after only a few months and had to be hospitalized for a period of time due to severe internal and gastrointestinal hemorrhaging. The problem became worse when doctors had to take emergency measures in order to prevent serious harm or death to the patients, due to the absence of an antidote or a reversing agent that would help in controlling the bleeding.
Xarelto Lawsuit File against Manufacturers
It was alleged by Virginia G. Stuntebeck in her lawsuit that Xarelto sold by the its manufacturers was a dangerous and defective drug and that patients and health providers were not warned of the risk of bleeding that is irreversible. Bayer AG and Janssen Pharmaceuticals, a business unit of the giant healthcare company Johnson & Johnson, were named defendants in the Xarelto lawsuit.
Subsequent Xarelto Lawsuits Filed
Since the filing of the Xarelto lawsuit by Virginia Stuntebeck, other patients who have sustained injuries as a result of using this anticoagulant drug have also filed claims against the manufacturers. A widow who lost her husband due to the very fatal subdural hemorrhaging after being prescribed with Xarelto has also filed a Xarelto lawsuit in a Florida court.
A Xarelto lawsuit has also been filed in Vermont this time by the heirs of a patient who died to uncontrollable bleeding after only less than 10 days from taking Xarelto. Other Xarelto lawsuits have also been filed by other patients injured by this medication aside from the cases in Vermont and Florida.
Reports of Adverse Effects
It has been revealed, based on the adverse events reports gathered by the Food and Drug Administration (FDA), that there have already been over 2,100 patients who experienced severe complications associated with the Xarelto drug. Due to serious bleeding, roughly 900 patients out of this number have been hospitalized with about 183 patients succumbing to death.
Will Xarelto Go the Way of Pradaxa?
In just a matter of two years, Xarelto has already dominated the market for blood thinners and have in fact surpassed Pradaxa, its closest competitor. It is not only in sales that it has surpassed Pradaxa but also in the number of severe complications reported by patients.
It will not be a surprise if Xarelto lawsuits will exceed those of Pradaxa, legal experts say, based on the rate adverse events involving Xarelto are being reported. At the moment, pending Pradaxa lawsuits have been placed at over 4,000 cases which are reportedly being settled by its manufacturer for an amount of $650 million. The question right now is whether Xarelto will go the way of Pradaxa lawsuits in view of the very similar circumstances.
References:
dockets.justia.com/docket/pennsylvania/paedce/2:2014cv01097/487939
fiercepharma.com/story/sources-bayer-jjs-xarelto-faces-first-us-lawsuits/2014-06-16
Plaintiff Experienced Complications after Xarelto Prescription
Virginia Stuntebeck stated in her complaint that she was prescribed with Xarelto medication by her attending physician for her atrial fibrillation in July 2012. She started experiencing severe complications after only a few months and had to be hospitalized for a period of time due to severe internal and gastrointestinal hemorrhaging. The problem became worse when doctors had to take emergency measures in order to prevent serious harm or death to the patients, due to the absence of an antidote or a reversing agent that would help in controlling the bleeding.
Xarelto Lawsuit File against Manufacturers
It was alleged by Virginia G. Stuntebeck in her lawsuit that Xarelto sold by the its manufacturers was a dangerous and defective drug and that patients and health providers were not warned of the risk of bleeding that is irreversible. Bayer AG and Janssen Pharmaceuticals, a business unit of the giant healthcare company Johnson & Johnson, were named defendants in the Xarelto lawsuit.
Subsequent Xarelto Lawsuits Filed
Since the filing of the Xarelto lawsuit by Virginia Stuntebeck, other patients who have sustained injuries as a result of using this anticoagulant drug have also filed claims against the manufacturers. A widow who lost her husband due to the very fatal subdural hemorrhaging after being prescribed with Xarelto has also filed a Xarelto lawsuit in a Florida court.
A Xarelto lawsuit has also been filed in Vermont this time by the heirs of a patient who died to uncontrollable bleeding after only less than 10 days from taking Xarelto. Other Xarelto lawsuits have also been filed by other patients injured by this medication aside from the cases in Vermont and Florida.
Reports of Adverse Effects
It has been revealed, based on the adverse events reports gathered by the Food and Drug Administration (FDA), that there have already been over 2,100 patients who experienced severe complications associated with the Xarelto drug. Due to serious bleeding, roughly 900 patients out of this number have been hospitalized with about 183 patients succumbing to death.
Will Xarelto Go the Way of Pradaxa?
In just a matter of two years, Xarelto has already dominated the market for blood thinners and have in fact surpassed Pradaxa, its closest competitor. It is not only in sales that it has surpassed Pradaxa but also in the number of severe complications reported by patients.
It will not be a surprise if Xarelto lawsuits will exceed those of Pradaxa, legal experts say, based on the rate adverse events involving Xarelto are being reported. At the moment, pending Pradaxa lawsuits have been placed at over 4,000 cases which are reportedly being settled by its manufacturer for an amount of $650 million. The question right now is whether Xarelto will go the way of Pradaxa lawsuits in view of the very similar circumstances.
References:
dockets.justia.com/docket/pennsylvania/paedce/2:2014cv01097/487939
fiercepharma.com/story/sources-bayer-jjs-xarelto-faces-first-us-lawsuits/2014-06-16